Clinical trial
Treatment of Childhood Onset Psychiatric Disorders With Intravenous…
NCT00001768 · National Institute of Mental Health (NIMH), NIH · Completed
Key facts
| NCT number | NCT00001768 |
|---|---|
| Title | Treatment of Childhood Onset Psychiatric Disorders With Intravenous Immunoglobulin (IVIg) |
| Official title | Childhood Onset Psychiatric Disorders: A Placebo Controlled Double-Blind Crossover Trial of Intravenous Immunoglobulin (IVIg) |
| Lead sponsor | National Institute of Mental Health (NIMH), NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Autoimmune Diseases, Mental Disorders Diagnosed in Childhood, Schizophrenia |
| Intervention type | Drug |
| Interventions | Intravenous immunoglobulin |
| Enrollment | 10 |
| Start date | Oct 1, 1997 |
| Completion | Jun 1, 2000 |
| First posted | Dec 10, 2002 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: